Variable | No of patients | No of deaths | p value (Log Rank Test) | |
Age (median 56) | ≤56 ≥56 | 28 29 | 7 9 | 0.374 |
BSI change after 6 months | ≤1 ≥1 | 20 23 | 2 9 | 0.011* |
BSI change after 12 months | ≤1 ≥1 | 25 23 | 3 11 | 0.016* |
The number of BSI (median 0.676) | ≤0.676 ≥0.676 | 28 29 | 8 8 | 0.743 |
The number of hot spots (median 7) | ≤7 ≥7 | 30 27 | 10 6 | 0.644 |
Extra osseous metastasis at bone metastasis onset | presence absence | 31 26 | 7 9 | 0.986 |
CA15-3 change after 6 months | ≤1 ≥1 | 28 20 | 6 7 | 0.364 |
CA15-3 change after 12 months | ≤1 ≥1 | 29 18 | 4 7 | 0.0534 |
CA15-3 normal or abnormal at bone metastasis onset | normal abnormal | 25 29 | 7 7 | 0.894 |
CEA change after 6 months | ≤1 ≥1 | 24 17 | 5 6 | 0.405 |
CEA change after 12 months | ≤1 ≥1 | 27 17 | 5 6 | 0.144 |
CEA normal or abnormal at bone metastasis onset | normal abnormal | 28 22 | 7 6 | 0.968 |
With hormone therapy or without hormone therapy | without with | 20 37 | 8 7 | 0.50 |
With anticancer drug or without anticancer drug. | without with | 19 38 | 3 13 | 0.301 |